Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients.
Grubczak KamilAnna GrzeszczukMonika GrothAnna HryniewiczAnna Kretowska-GrunwaldRobert FlisiakMarcin MoniuszkoPublished in: Viruses (2021)
Therapy with pegIFN-α/RBV demonstrated a significant effect on regulatory T cells in the course of HIV and/or HCV infection indicating a crucial role in the anti-viral immune response.
Keyphrases
- regulatory t cells
- hepatitis c virus
- dendritic cells
- human immunodeficiency virus
- immune response
- antiretroviral therapy
- hiv positive
- hiv infected
- end stage renal disease
- hiv testing
- ejection fraction
- newly diagnosed
- hiv aids
- prognostic factors
- stem cells
- patient reported outcomes
- south africa
- peritoneal dialysis
- bone marrow
- patient reported